Cargando…

Depletion of B cell-activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease

Obesity-induced adipose-tissue dysfunction is a critical contributor to the pathogenesis of nonalcoholic fatty liver disease (NAFLD). B cell-activating factor (BAFF) is an adipokine related to impaired insulin sensitivity, and the serum BAFF concentration is associated with NAFLD severity. In this s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakamura, Yoshiko, Abe, Masanori, Kawasaki, Keitarou, Miyake, Teruki, Watanabe, Takao, Yoshida, Osamu, Hirooka, Masashi, Matsuura, Bunzo, Hiasa, Yoichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353938/ https://www.ncbi.nlm.nih.gov/pubmed/30700810 http://dx.doi.org/10.1038/s41598-018-37403-y

Ejemplares similares

Role of B Cell-Activating Factor in Fibrosis Progression in a Murine Model of Non-Alcoholic Steatohepatitis
por: Kanemitsu-Okada, Kozue, et al.
Publicado: (2023)

B cell activating factor in obesity is regulated by oxidative stress in adipocytes
por: Tada, Fujimasa, et al.
Publicado: (2013)

Hyperuricemia Is a Risk Factor for the Onset of Impaired Fasting Glucose in Men with a High Plasma Glucose Level: A Community-Based Study
por: Miyake, Teruki, et al.
Publicado: (2014)

Nonalcoholic fatty liver with a hepatic arterial buffer response strongly associated with future metabolic disease
por: Hirooka, Masashi, et al.
Publicado: (2017)

Treatment on the Spleen Prevents the Progression of Secondary Sarcopenia in Patients With Liver Cirrhosis
por: Hirooka, Masashi, et al.
Publicado: (2020)

Plasma Fatty Acid Composition Is Associated with Histological Findings of Nonalcoholic Steatohepatitis
por: Miyake, Teruki, et al.
Publicado: (2022)

Characterization of Liver Monocytic Myeloid-Derived Suppressor Cells and Their Role in a Murine Model of Non-Alcoholic Fatty Liver Disease
por: Yao, Liying, et al.
Publicado: (2016)

Nonalcoholic fatty liver disease is a risk factor for glucose intolerance onset in men regardless of alanine aminotransferase status
por: Miyake, Teruki, et al.
Publicado: (2021)

Additional Effect of Luseogliflozin on Semaglutide in Nonalcoholic Steatohepatitis Complicated by Type 2 Diabetes Mellitus: An Open-Label, Randomized, Parallel-Group Study
por: Miyake, Teruki, et al.
Publicado: (2022)

Effects of Motilin Receptor Agonists and Ghrelin in Human motilin receptor Transgenic Mice
por: Kawamura, Tomoe, et al.
Publicado: (2019)

Quantitative imaging of fibrotic and morphological changes in liver of non-alcoholic steatohepatitis (NASH) model mice by second harmonic generation (SHG) and auto-fluorescence (AF) imaging using two-photon excitation microscopy (TPEM)
por: Yamamoto, Shin, et al.
Publicado: (2016)

The Serum Creatinine Level Might Be Associated with the Onset of Impaired Fasting Glucose: A Community-based Longitudinal Cohort Health Checkup Study
por: Yoshida, Naohiko, et al.
Publicado: (2018)

Usefulness of a New Three-Dimensional Simulator System for Radiofrequency Ablation
por: Hirooka, Masashi, et al.
Publicado: (2016)

Protein Kinase R Modulates c-Fos and c-Jun Signaling to Promote Proliferation of Hepatocellular Carcinoma with Hepatitis C Virus Infection
por: Watanabe, Takao, et al.
Publicado: (2013)

Relationship between body composition and the histology of non‐alcoholic fatty liver disease: a cross‐sectional study
por: Miyake, Teruki, et al.
Publicado: (2021)

Relationship between urine pH and abnormal glucose tolerance in a community‐based study
por: Yoshida, Sakiko, et al.
Publicado: (2017)

Low Urine pH Is Associated with Non-alcoholic Fatty Liver Disease: A Community-based Cross-sectional Study
por: Miyake, Teruki, et al.
Publicado: (2018)

Ipragliflozin Ameliorates Liver Damage in Non-alcoholic Fatty Liver Disease
por: Miyake, Teruki, et al.
Publicado: (2018)

Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: A longitudinal cohort study
por: Okamoto, Masashi, et al.
Publicado: (2018)

Observational Study on Unhealthy Eating Behavior and the Effect of Sodium-Glucose Cotransporter 2 Inhibitors: The Luseogliflozin Ehime Diabetes Study
por: Furukawa, Shinya, et al.
Publicado: (2022)

Destructive Thyroiditis Induced by Lenvatinib in Three Patients with Hepatocellular Carcinoma
por: Hirooka, Masashi, et al.
Publicado: (2018)

Radiofrequency Ablation Covering the Entire Tumor Blood Drainage Area Improves Survival in Hepatocellular Carcinoma
por: Hirooka, Masashi, et al.
Publicado: (2021)

The long noncoding RNA of RMRP is downregulated by PERK, which induces apoptosis in hepatocellular carcinoma cells
por: Yukimoto, Atsushi, et al.
Publicado: (2021)

Development of a method for measuring spleen stiffness by transient elastography using a new device and ultrasound-fusion method
por: Tanaka, Takaaki, et al.
Publicado: (2021)

Cisterna chyli as an optimal marker of tolvaptan response in severe cirrhotic ascites
por: Hirooka, Masashi, et al.
Publicado: (2022)

Fatty liver with metabolic disorder, such as metabolic dysfunction‐associated fatty liver disease, indicates high risk for developing diabetes mellitus
por: Miyake, Teruki, et al.
Publicado: (2022)

Accurate reflection of hepatic venous pressure gradient by spleen stiffness measurement in patients with low controlled attenuation parameter values
por: Hirooka, Masashi, et al.
Publicado: (2021)

The mechanism of increased intestinal palmitic acid absorption and its impact on hepatic stellate cell activation in nonalcoholic steatohepatitis
por: Hanayama, Masakazu, et al.
Publicado: (2021)

Combined evaluation of Fibrosis‐4 index and fatty liver for stratifying the risk for diabetes mellitus
por: Todo, Yasuhiko, et al.
Publicado: (2022)

Stimulated hepatic stellate cell promotes progression of hepatocellular carcinoma due to protein kinase R activation
por: Imai, Yusuke, et al.
Publicado: (2019)

Histological assessment of the efficacy of drug-eluting beads in portal tumor thrombosis of hepatocellular carcinoma
por: Imai, Yusuke, et al.
Publicado: (2016)

Oral administration of human carbonic anhydrase I suppresses colitis in a murine inflammatory bowel disease model
por: Tange, Kazuhiro, et al.
Publicado: (2022)

Survival Improvements in Advanced Hepatocellular Carcinoma with Sequential Therapy by Era
por: Nakamura, Yoshiko, et al.
Publicado: (2023)

Therapeutic effects of the PKR inhibitor C16 suppressing tumor proliferation and angiogenesis in hepatocellular carcinoma in vitro and in vivo
por: Watanabe, Takao, et al.
Publicado: (2020)

Insulin‐like growth factor‐1 is inversely associated with liver fibrotic markers in patients with type 2 diabetes mellitus
por: Miyauchi, Shozo, et al.
Publicado: (2019)

Intranasal HBsAg/HBcAg-Containing Vaccine Induces Neutralizing Anti-HBs Production in Hepatitis B Vaccine Non-Responders
por: Shiraishi, Kana, et al.
Publicado: (2023)

Increased B Cell-Activating Factor Promotes Tumor Invasion and Metastasis in Human Pancreatic Cancer
por: Koizumi, Mitsuhito, et al.
Publicado: (2013)

Muscle atrophy as pre-sarcopenia in Japanese patients with chronic liver disease: computed tomography is useful for evaluation
por: Hiraoka, Atsushi, et al.
Publicado: (2015)

Schistosomiasis Diagnosed Using Laparoscopy and Colonoscopy
por: Koizumi, Yohei, et al.
Publicado: (2019)

Authors' Response to “Praziquantel Could Be the Appropriate Choice for the Diagnostic Treatment of Schistosomiasis”
por: Koizumi, Yohei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6cpadkp355brd67gauj86bfo2b